How many insider declarations does 瑞康医药 have?

瑞康医药 has filed 6 insider declarations with AMF.

Who is the top reporting insider at 瑞康医药?

The top reporting insider at 瑞康医药 is 张仁华, based on the count of public filings.

What is the net insider buy vs sell volume on 瑞康医药?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

瑞康医药: directors' dealings · France · AMF

SZSE:002589FR·AMFMcap 4.8Bn€

AMF ↗

Explore the full management transaction log of 瑞康医药, a listed issuer based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €4.8bn. The latest transaction was disclosed on 21 June 2024 — Purchase. Among the most active insiders: 张仁华. All data is accessible without an account.

6

Insider Decl.

0

Thresholds

·

1 ops.

Buy Volume

·

5 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

3.02 €

Income statement

Revenue7.30 Bn€

Gross profit776.1 M€11% margin

Net income16.1 M€0.2% margin

Balance sheet & cash

Market cap4.85 Bn€

Total debt4.60 Bn€

Free Cash Flow−13.1 M€

Last declaration on 21 June 2024

All Executives6 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations